Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 7, 2007, Pages 2615-2617

  Griffith, Matthew E ^a   Moon, James E ^a   Johnson, Erica N ^a   Clark, Kyra P ^a   Hawley, Joshua S ^a   Hospenthal, Duane R ^a   Murray, Clinton K ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; INOCULATION; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SURVIVAL RATE; SYRIAN HAMSTER; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CRICETINAE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; FEMALE; FLUOROQUINOLONES; INJECTIONS, INTRAPERITONEAL; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MESOCRICETUS; OFLOXACIN; SEROTYPING; SURVIVAL ANALYSIS;

EID: 34447261839     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00240-07     Document Type: Article

References (14)

1. Andes, D., and W. A. Craig. 2002. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrob. Agents Chemother. 46:1665-1670.
2. Arai, S., Y. Gohara, A. Akashi, K. Kuwano, M. Nishimoto, T. Yano, K. Oizumi, K. Takeda, and T. Yamaguchi. 1993. Effects of new quinolones on Mycoplasma pneumonia-infected hamsters. Antimicrob. Agents Chemother. 37:287-292.
3. Bal, A. M. 2005. Use of ciprofloxacin for treating leptospirosis - need for clinical trials. J. Med. Microbiol. 54:907.
4. Bedos, J. P., E. Azoulay-Dupuis, P. Moine, M. Muffat-Joly, B. Veber, J. J. Pocidalo, and E. Vallee. 1998. Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy. J. Pharmacol. Exp. Ther. 286:29-35.
5. Food and Drug Administration, U.S. Department of Health and Human Services. 2002. Guidance for industry and reviewers: estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Draft document, http://www.fda.gov/cber/gdlns/dose.pdf.
6. Griffith, M. E., D. R. Hospenthal, and C. K. Murray. 2006. Antimicrobial therapy of leptospirosis. Curr. Opin. Infect. Dis. 19:533-537.
7. Moon, J. E., M. W. Ellis, M. E. Griffith, J. S. Hawley, R. G. Rivard, S. McCall, D. R. Hospenthal, and C. K. Murray. 2006. Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. Antimicrob. Agents Chemother. 50:1989-1992.
8. Murray, C. K., and D. R. Hospenthal. 2004. Broth microdilution susceptibility testing for Leptospira spp. Antimicrob. Agents Chemother. 48:1548-1552.
9. Murray, C. K., and D. R. Hospenthal. 2006. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique. Antimicrob. Agents Chemother. 48:4002-4005.
10. Scaglione, F., J. W. Mouton, R. Mattina, and F. Fraschini. 2003. Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios. Antimicrob. Agents Chemother. 47:2749-2755.
11. Shalit, I., A. Barnea, and A. Shahar. 1989. Efficacy of ciprofloxacin against Leptospira interrogans serogroup icterohaemorrhagiae. Antimicrob. Agents Chemother. 33:788-789.
12. Takahata, M., M. Shimakura, R. Hori, K. Kizawa, Y. Todo, S. Minami, Y. Watanabe, and H. Narita. 2001. In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumonia. Antimicrob. Agents Chemother. 45:312-315.
13. Takashima, I., M. Ngoma, and N. Hashimoto. 1993. Antimicrobial effects of a new carboxyquinolone drug, Q35, on five serogroups of Leptospira interrogans. Antimicrob. Agents Chemother. 37:901-902.
14. Truccolo, J., F. Charavay, F. Merien, and P. Perolat. 2002. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob. Agents Chemother. 46:848-853.